We demonstrated that testosterone and estradiol improved overall NASH histological parameters, ameliorated hepatic fat accumulation, and decreased SREBP1c and FAS gene expression, compared with the ORX + HFHF group. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatohepatitis.